共 251 条
[31]
Blay JY(2017)Clinical outcomes of patients 80 years and older with soft tissue sarcoma J Orthop Sci 22 951-60
[32]
Chawla SP(2009)Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients Ann Surg Oncol 16 2579-4035
[33]
Kim DW(2018)The prognostic significance of surgical treatment for excessive elderly patients with soft tissue sarcoma Int J Clin Oncol 23 775-1410
[34]
Bui-Nguyen B(2019)The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial Eur J Cancer 109 51-1259
[35]
Casali PG(2011)Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk J Clin Oncol 29 4029-1988
[36]
Schoffski P(2017)Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcoma (GeDDiS): a randomised controlled phase 3 trial Lancet Oncol 18 1397-1416
[37]
Chawla S(2018)Outcomes of elderly patients with advanced soft tissue sarcoma treated with first-line chemotherapy: a pooled analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials Oncologist 23 1250-136
[38]
Maki RG(2015)Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy Circulation 131 1981-44
[39]
Italiano A(2014)Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series Clin Sarcoma Res. 4 14-4734
[40]
Gelderblom H(2016)The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: a Japanese Musculoskeletal Oncology Group study Cancer 122 1408-519